文献速递肝胆胰外科围术期管理与 ERAS

大范围肝切除术后结局的性别差异:雌激素的新作用?

Sex Disparities in Outcomes Following Major Liver Surgery: New Powers of Estrogen?
PubMed 文献 · Ann Surg · 2022-07-27

该研究分析连续肝切除患者(55例女性、67例男性)及国际ALPPS登记数据(449例女性、729例男性),发现男性在大范围肝切除后严重并发症更多、肝功能不全(MELD)更高,男性是ALPPS术后并发症的预测因素;女性ALPPS间隔期更短,但绝经后亚组无此优势,小鼠实验提示雌激素驱动这些性别差异。

要点

  • 男性大范围肝切除后严重并发症和肝功能不全风险高于女性。
  • 男性是ALPPS术后并发症和肝功能不全的独立预测因素。
  • 女性ALPPS间隔期更短的优势在绝经后消失,雌激素可能是驱动因素。

核心结论

  • 男性大范围肝手术后结局较差,女性ALPPS间隔期较短,但不一定代表女性肝脏再生能力更强。
  • 绝经后女性间隔期优势消失及小鼠实验提示雌激素是这些性别差异的驱动因素。
  • 雌激素的益处需要在接受大范围肝手术的绝经后女性和男性中评估。

研究设计与样本

  • 分析连续肝切除患者(55例女性、67例男性)及国际ALPPS登记数据(449例女性、729例男性)。
  • 建立雌-雄ALPPS小鼠模型用于验证和机制探讨。
  • 比较采用t检验、χ²检验或Mann-Whitney检验,并进行单因素/多因素分析。

主要发现

  • 大范围肝切除后,男性严重并发症更多(P=0.03),肝功能不全(MELD)更高(P=0.0001)。
  • 多因素分析显示男性是ALPPS一期术后并发症的预测因素(OR=1.78;95%CI:1.126-2.89;P=0.01)。
  • 男性是ALPPS二期术后肝功能不全加重的预测因素(OR=1.93;95%CI:1.01-3.69;P=0.045)。
  • 女性ALPPS间隔期<2周的比例为64%,男性为56%(P=0.01),但绝经后亚组无此差异。
  • 小鼠ALPPS一期术后女性再生快于男性,雌激素拮抗后该效应消失。

关键数值与推荐

  • 严重并发症定义为Clavien-Dindo≥3b级。
  • 肝功能不全以MELD评分评估。
  • ALPPS间隔期以<2周为界比较。

临床怎么用

  • 临床应关注男性大范围肝切除术后并发症和肝功能不全风险。
  • 对绝经后女性及男性大范围肝手术患者,可考虑评估雌激素相关干预的获益。
  • ALPPS间隔期决策需考虑性别和绝经状态,而非仅依据女性间隔期较短。

局限性

  • 原文未报告连续肝切除患者的具体来源和纳入时间。
  • 原文未报告小鼠实验的具体样本量和机制细节。
  • 原文未报告多因素分析的完整协变量列表。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To explore potential sex differences in outcomes and regenerative parameters post major hepatectomies. BACKGROUND: Although controversial, sex differences in liver regeneration have been reported for animals. Whether sex disparity exists in human liver regeneration is unknown. METHODS: Data from consecutive hepatectomy patients (55 females, 67 males) and from the international ALPPS (Associating-Liver-Partition-and-Portal-vein-ligation-for-Staged-hepatectomy, a two stage hepatectomy) registry (449 females, 729 males) were analyzed. Endpoints were severe morbidity (≥3b Clavien-Dindo grades), Model for End-stage Liver Disease (MELD) scores, and ALPPS interstage intervals. For validation and mechanistic insight, female-male ALPSS mouse models were established. t , χ 2 , or Mann-Whitney tests were used for comparisons. Univariate/multivariate analyses were performed with sensitivity inclusion. RESULTS: Following major hepatectomy (Hx), males had more severe complications ( P =0.03) and higher liver dysfunction (MELD) P =0.0001) than females. Multivariate analysis established male sex as a predictor of complications after ALPPS stage 1 (odds ratio=1.78; 95% confidence interval: 1.126-2.89; P =0.01), and of enhanced liver dysfunction after stage 2 (odds ratio=1.93; 95% confidence interval: 1.01-3.69; P =0.045). Female patients displayed shorter interstage intervals (<2 weeks, 64% females versus 56% males, P =0.01), however, not in postmenopausal subgroups. In mice, females regenerated faster than males after ALPPS stage 1, an effect that was lost upon estrogen antagonism. CONCLUSIONS: Poorer outcomes after major surgery in males and shorter ALPPS interstage intervals in females not necessarily suggest a superior regenerative capacity of female liver. The loss of interstage advantages in postmenopausal women and the mouse experiments point to estrogen as the driver behind these sex disparities. Estrogen's benefits call for an assessment in postmenopausal women, and perhaps men, undergoing major liver surgery.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Birrer DL, Linecker M, López-López V, et al. Sex Disparities in Outcomes Following Major Liver Surgery: New Powers of Estrogen? Ann Surg. 2022. PMID: 35894447. doi:10.1097/SLA.0000000000005635

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。